These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8981182)

  • 1. Inhibitory and bactericidal activity of rokitamycin against Helicobacter pylori and morphological alterations.
    Brenciaglia MI; Fornara AM; Scaltrito MM; Braga PC
    J Chemother; 1996 Dec; 8(6):425-31. PubMed ID: 8981182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of clarithromycin against intracellular Helicobacter pylori.
    Piccolomini R; Di Bonaventura G; Picciani C; Laterza F; Vecchiet J; Neri M
    Antimicrob Agents Chemother; 2001 May; 45(5):1568-71. PubMed ID: 11302831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of anti-ulcer agents on antibiotic activity against Helicobacter pylori.
    Sunairi M; Watanabe K; Suzuki T; Tanaka N; Kuwayama H; Nakajima M
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S121-4. PubMed ID: 7735928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro anti-Helicobacter pylori activity of ebrotidine.
    Palacín C; Tarragó C; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):471-4. PubMed ID: 9205746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori.
    Dai G; Cheng N; Dong L; Muramatsu M; Xiao S; Wang MW; Zhu DX
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3468-73. PubMed ID: 16048962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan.
    Cheng A; Sheng WH; Liou JM; Wang HP; Wu MS; Lin JT; Chang SC
    J Microbiol Immunol Infect; 2015 Feb; 48(1):72-9. PubMed ID: 23036269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The post-antibiotic effects of rokitamycin (a 16-membered ring macrolide) on susceptible and erythromycin-resistant strains of Streptococcus pyogenes.
    Braga PC; Culici M; Dal Sasso M
    Int J Antimicrob Agents; 2004 Sep; 24(3):254-60. PubMed ID: 15325429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the degree of susceptibility of Streptococcus pyogenes erythromycin-resistant strains to rokitamycin (a 16-membered macrolide) using the Epsilometer test.
    Crotti D; Rossetti R; Braga PC
    Drugs Exp Clin Res; 2004; 30(1):17-26. PubMed ID: 15134387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of rokitamycin-induced morphostructural alterations in Helicobacter pylori by atomic force microscopy.
    Braga PC; Ricci D
    Chemotherapy; 2000; 46(1):15-22. PubMed ID: 10601793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic MICs and short time-killing against Helicobacter pylori: therapeutic potential of kanamycin.
    Irie Y; Tateda K; Matsumoto T; Miyazaki S; Yamaguchi K
    J Antimicrob Chemother; 1997 Aug; 40(2):235-40. PubMed ID: 9301989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal activity of levofloxacin, gatifloxacin, penicillin, meropenem and rokitamycin against Bacillus anthracis clinical isolates.
    Drago L; De Vecchi E; Lombardi A; Nicola L; Valli M; Gismondo MR
    J Antimicrob Chemother; 2002 Dec; 50(6):1059-63. PubMed ID: 12461034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori].
    Sugita K; Katouno Y; Uchida H; Kobayashi Y
    Jpn J Antibiot; 2002 Dec; 55(6):771-7. PubMed ID: 12621731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of rokitamycin, a new macrolide, against Borrelia burgdorferi.
    Cinco M; Padovan D; Stinco G; Trevisan G
    Antimicrob Agents Chemother; 1995 May; 39(5):1185-6. PubMed ID: 7625812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked susceptibility of South African Helicobacter pylori strains to ciprofloxacin and amoxicillin: clinical implications.
    Tanih NF; Okeleye BI; Naidoo N; Clarke AM; Mkwetshana N; Green E; Ndip LM; Ndip RN
    S Afr Med J; 2010 Jan; 100(1):49-52. PubMed ID: 20429489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo bactericidal activity of Tinospora sagittata (Oliv.) Gagnep. var. craveniana (S.Y.Hu) Lo and its main effective component, palmatine, against porcine Helicobacter pylori.
    Rong Q; Xu M; Dong Q; Zhang Y; Li Y; Ye G; Zhao L
    BMC Complement Altern Med; 2016 Aug; 16(1):331. PubMed ID: 27576439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides.
    Braga PC
    J Chemother; 2002 Apr; 14(2):115-31. PubMed ID: 12017366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of rokitamycin and other macrolide antibiotics on Mycoplasma pneumoniae in L cells.
    Misu T; Arai S; Furukawa M; Yamamoto Y; Miyazaki T
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1843-5. PubMed ID: 3124740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey.
    Caliskan R; Tokman HB; Erzin Y; Saribas S; Yuksel P; Bolek BK; Sevuk EO; Demirci M; Yılmazli O; Akgul O; Kalayci F; Cakan H; Salih B; Bal K; Kocazeybek B
    Rev Soc Bras Med Trop; 2015; 48(3):278-84. PubMed ID: 26108005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of minimal inhibitory concentration (MIC) and minimal lethal concentration (MLC) values for tetracycline, monocycline, erythromycin and rokitamycin against eleven strains of Chlamydia trachomatis].
    Bianchi A; Scieux C; Robache S; Vassias I; Pérol Y
    Pathol Biol (Paris); 1991 May; 39(5):442-5. PubMed ID: 1881673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of rokitamycin compared with that of other macrolides.
    Yu KW; Briones F; Chin NX; Neu HC
    Diagn Microbiol Infect Dis; 1991; 14(4):331-5. PubMed ID: 1889182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.